Industrial, Manufacturing & Heavy Industry Market News

Lateral flow assay market worth 8.24 billion USD by 2022 according to new research report

Lateral flow assay market worth 8.24 billion USD by 2022 according to new research report

According to a new market research "Lateral Flow Assay Market by Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwich), End User - Global Forecast to 2022", published by MarketsandMarkets™, the market is expected to reach USD 8.24 Billion by 2022 from an estimated USD 5.55 Billion in 2017, at a CAGR of 8.2%.

- Advertising -

Browse  218  Market  Data  Tables  and  44  Figures  spread  through  283  Pages  and  in-depth  TOC  on  "Lateral Flow Assay  Market"

www.marketsandmarkets.com/Market-R…m_campaign=PaidPR

The high prevalence of infectious diseases worldwide, rapidly growing geriatric population, growing demand for point-of-care testing, and rising use of home-based lateral flow assay devices are the significant growth drivers of the Lateral Flow Assay Market.

"By product, the kits & reagents segment accounted for the largest share of the market in 2016." 

On the basis of product, the kits & reagents segment accounted for the largest share of the global Lateral Flow Assay Market. The large share of this segment can be attributed to the increasing application of lateral flow kits & reagents for point-of-care testing, growing burden of chronic diseases, and increasing use of lateral flow kits in home care.

- Advertising -

Download PDF Brochure at www.marketsandmarkets.com/pdfdownl…m_campaign=paidpr

"By application, the clinical/point-of-care testing segment held the largest market share in 2016." 

Based on application, the clinical/point-of-care testing segment accounted for the largest share of the LFA market. The rise in population levels & prevalence of chronic diseases, growing pressure to reduce healthcare costs, and increasing demand for patient-centric care are the major factors driving the growth of the clinical/POC testing market.

"North America dominated the market in 2016." 

North America accounted for the largest share of the Lateral Flow Assay Market in 2016, followed by Europe and Asia-Pacific. The presence of a highly developed healthcare system, rising geriatric population, increasing incidence of chronic diseases, quick adoption of new innovative products, and a large number of lateral flow assay kits manufacturing companies in this region are the major factors responsible for the largest share of North America in the Lateral Flow Assay Market.

The prominent players in the global Lateral Flow Assay Market are Alere, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Siemens AG (Germany), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Johnson & Johnson (U.S.), Bio-Rad Laboratories, Inc.

(U.S.), Thermo Fisher Scientific Inc. (U.S.), QIAGEN N.V. (Netherlands), and PerkinElmer, Inc.

(U.S.).

Report: www.marketsandmarkets.com/speaktoa…m_campaign=paidpr

 

News From

MarketsandMarkets™ - Business ResearchMarketsandMarkets™
Category: Market Research Publishers and RetailersCompany profile: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...